Ireland (IE)

Delineation of the adult phenotype of Coffin–Siris syndrome in 35 individuals (2023) Schmetz A, Lüdecke HJ, Surowy H, Sivalingam S, Bruel AL, Caumes R, Charles P, et al. Journal article A Multifunctional Scaffold for Bone Infection Treatment by Delivery of microRNA Therapeutics Combined With Antimicrobial Nanoparticles (2023) Sadowska JM, Power RN, Genoud KJ, Matheson A, González-Vázquez A, Costard L, Eichholz K, et al. Journal article Ecological validity of a deep learning algorithm to detect gait events from real-life walking bouts in mobility-limiting diseases (2023) Romijnders R, Salis F, Hansen C, Küderle A, Paraschiv-Ionescu A, Cereatti A, Alcock L, et al. Journal article Proceedings of the Collaborative Research Network Meeting at the GRAPPA 2022 Annual Meeting. (2023) Ng BCK, Jadon D, Behrens F, de Wit M, FitzGerald O, Gladman DD, Mease PJ, et al. Journal article Treatment of pulpal and apical disease: The European Society of Endodontology (ESE) S3-level clinical practice guideline (2023) Duncan HF, Kirkevang LL, Peters OA, El-Karim I, Krastl G, Del Fabbro M, Chong BS, et al. Journal article The impact of the temporal sequence of cranial radiotherapy and platin-based chemotherapy on hearing impairment in pediatric and adolescent CNS and head-and-neck cancer patients: A report from the PanCareLIFE consortium (2023) Scobioala S, Parfitt R, Matulat P, Byrne J, Langer T, Troschel FM, Hesping AE, et al. Journal article Constraints on the Intergalactic Magnetic Field Using Fermi-LAT and H.E.S.S. Blazar Observations (2023) Aharonian F, Aschersleben J, Backes M, Martins VB, Batzofin R, Becherini Y, Berge D, et al. Journal article Global challenges in access to diagnostics and treatment for neuroendocrine tumor (NET) patients (2023) Dureja S, McDonnell M, Van Genechten D, Bouvier C, Kolarova T, O'Toole D, Singh H, et al. Journal article, Review article Early versus Later Anticoagulation for Stroke with Atrial Fibrillation. (2023) Fischer U, Koga M, Strbian D, Branca M, Abend S, Trelle S, Paciaroni M, et al. Journal article Rationale and trial design of NATALEE: a Phase III trial of adjuvant ribociclib + endocrine therapy versus endocrine therapy alone in patients with HR+/HER2− early breast cancer (2023) Slamon DJ, Fasching P, Hurvitz S, Chia S, Crown J, Martín M, Barrios CH, et al. Journal article